ARID1A and ovarian carcinoma: Both findings go together with previously published data on ARID1A mutated tumors, including ovarian cancer, hepatocellular carcinoma, colorectal adenocarcinoma, and non-small-cell lung cancer (NSCLC) [15,16,25,26].